0000899243-20-002213.txt : 20200128
0000899243-20-002213.hdr.sgml : 20200128
20200128160723
ACCESSION NUMBER: 0000899243-20-002213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200126
FILED AS OF DATE: 20200128
DATE AS OF CHANGE: 20200128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shaff Eric D.
CENTRAL INDEX KEY: 0001643734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 20554290
MAIL ADDRESS:
STREET 1: C/O SERES HEALTH, INC.
STREET 2: 161 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-26
0
0001609809
Seres Therapeutics, Inc.
MCRB
0001643734
Shaff Eric D.
C/O SERES THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
CEO and President
COMMON STOCK
2020-01-26
4
M
0
20000
A
32842
D
RESTRICTED STOCK UNITS
2020-01-26
4
M
0
20000
0.00
D
Common Stock
20000
0
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The restricted stock units are fully vested and do not have an expiration date.
/s/ Thomas J. DesRosier, attorney-in-fact for Eric D. Shaff
2020-01-28